← Leaderboards
Mary J Cloninger
Montana State University (Bozeman)
$3,496,615
Attributed
$3,496,615
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $367.7K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$3,496,615 · 2
By mechanism
R01$3,494,115 · 1
R13$2,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorBinding (Molecular Function)BaseFundingTherapeutic AgentsProgramsMalignant NeoplasmsArchitectureAffinityCarbohydratesBiological ModelsProteinsDesignExhibitsLactoseCancer CellGalectin 3MediatingDendrimersNeoplasm MetastasisPolymersPublic Health Medicine (Field)Alzheimer&AposAcquired Immunodeficiency Syndrome
Grant awards (18)
Using Dendrimers to Design Multivalent Therapeutic Agents$302,120
R01 · FY2015 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$65,535
R01 · FY2015 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$292,990
R01 · FY2014 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$291,546
R01 · FY2013 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$302,120
R01 · FY2012 · GM · contact PI
Symposium funding request for "Multivalent Drug Design"$2,500
R13 · FY2011 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$292,662
R01 · FY2010 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$277,395
R01 · FY2009 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$41,860
R01 · FY2009 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$14,998
R01 · FY2009 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$277,395
R01 · FY2008 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agents$277,395
R01 · FY2007 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agent$68,097
R01 · FY2006 · GM · contact PI
Using Dendrimers to Design Multivalent Therapeutic Agent$194,019
R01 · FY2005 · GM
Using Dendrimers to Design Multivalent Therapeutic Agent$194,019
R01 · FY2004 · GM
Using Dendrimers to Design Multivalent Therapeutic Agent$194,019
R01 · FY2003 · GM
Using Dendrimers to Design Multivalent Therapeutic Agent$194,019
R01 · FY2002 · GM
Using Dendrimers to Design Multivalent Therapeutic Agent$213,926
R01 · FY2001 · GM